FDA Inspection 1062724 — Eversight Illinois, Bloomington
The FDA completed an inspection of Eversight Illinois, Bloomington on Jul 24, 2018 in Bloomington, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 24, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bloomington, IL (United States)